Bursitis epidemiology and demographics

Revision as of 20:46, 29 July 2020 by WikiBot (talk | contribs) (Bot: Removing from Primary care)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Bursitis Microchapters


Patient Information


Historical perspective




Differentiating Bursitis from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


History and Symptoms

Physical Examination

Laboratory Findings

X Ray




Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bursitis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Bursitis epidemiology and demographics

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bursitis epidemiology and demographics

CDC on Bursitis epidemiology and demographics

Bursitis epidemiology and demographics in the news

Blogs on Bursitis epidemiology and demographics

Directions to Hospitals Treating Bursitis

Risk calculators and risk factors for Bursitis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]


Bursitis accounts for 400 visits per 100,000 visits to primary care clinics. The exact prevalence and incidence of bursitis are unknown.[1]

Epidemiology and Demographics

Prevalence and Incidence

  • The exact incidence and prevalence of bursitis are not known.
  • The incidence of septic olecranon and prepatellar bursitis is estimated to be 10 to 100 cases per 100,000 hospital admissions.[1]
  • In sport medicine practice, the incidence of trochanteric bursitis was estimated to be 560 cases per 100,000 cases.[2]


  • Prepatellar bursitis can affect all age groups. However, the incidence of septic bursitis is higher in children, particularly immunocompromised patients.
  • Olecranon bursitis affects middle-aged people (between the ages of 30 and 60 years).
  • Trochanteric bursitis can affect all age groups, though the incidence of trochanteric bursitis may be higher in middle-aged to elderly adults.[3]



  • There is no racial predilection to bursitis.


  1. 1.0 1.1 McAfee JH, Smith DL (1988). "Olecranon and prepatellar bursitis. Diagnosis and treatment". West J Med. 149 (5): 607–10. PMC 1026560. PMID 3074561.
  2. Brinks A, van Rijn RM, Bohnen AM, Slee GL, Verhaar JA, Koes BW; et al. (2007). "Effect of corticosteroid injection for trochanter pain syndrome: design of a randomised clinical trial in general practice". BMC Musculoskelet Disord. 8: 95. doi:10.1186/1471-2474-8-95. PMC 2045096. PMID 17880718.
  3. 3.0 3.1 Govaert LH, van Dijk CN, Zeegers AV, Albers GH (2012). "Endoscopic bursectomy and iliotibial tract release as a treatment for refractory greater trochanteric pain syndrome: a new endoscopic approach with early results". Arthrosc Tech. 1 (2): e161–4. doi:10.1016/j.eats.2012.06.001. PMC 3678627. PMID 23766989.

Template:WH Template:WS